Medius Associates
Medius provides an unrivalled range of specialised business development training solutions to cater for all levels of learning. This range extends from client specific in house tutorials through open enrolment courses to the Pharmaceutical Licensing Group’s distance learning modular MSc course.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
Putting our core values into practice at the Porterhouse summer social
Press Releases | August 15, 2019 | Porterhouse Medical Group
As a reward for all our hard work and in keeping with our core values, which include ‘family’ and ‘humour and happiness’, the teams at Porterhouse enjoy regular socials.For our...
Spotlight interview: 15 minutes on patient engagement in pharma
White Papers and Resources | August 14, 2019 | OPEN Health
Richard Jones, Managing Director Patient Engagement, OPEN Health Patient and Brand Communications, takes 15 minutes to answer some key questions on patient engagement in pharma
A new leadership appointment at Porterhouse Medical
Press Releases | August 14, 2019 | Porterhouse Medical Group
Porterhouse Medical Group is thrilled to announce the promotion of Jamie Harrison to Scientific Team Lead.Jamie is a key member of the Scientific Services team and has been central to...
How is the NHS Long-term Plan being put into action?
White Papers and Resources | August 12, 2019 | Wilmington Healthcare
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published
Rob Pilbrow joins OPEN Health as Global Managing Director, Medical Writing
Press Releases | August 12, 2019 | OPEN Health
OPEN Health Group have appointed Rob Pilbrow into the newly formed role of Global Managing Director, Medical Writing.
Lucid Group supercharges its client services team with four spellbinding new hires
Press Releases | August 9, 2019 | Lucid Group Communications Limited
Lucid Group makes four magical additions to its client services team!Annabel Lloyd joins Vivid as an account director. With experience in a variety of therapy areas from immunology, oncology, CVD...
Bedrock LEAPs to new heights
Press Releases | August 7, 2019 | Resonant Group
What do our future leaders say about LEAP?
Power to the People: Why consultation is key for improved patient outcomes
White Papers and Resources | August 5, 2019 | Say Communications
Meningitis Research Foundation has been working with Say Communications to help boost our public consultation on a Roadmap to Defeat Meningitis. But with over 100 experts providing detailed information on...
Senior promotions continue at Porterhouse Medical
Press Releases | August 5, 2019 | Porterhouse Medical Group
Porterhouse Medical Group is delighted to announce the promotion of Claire Pullen to senior account director.Claire has made a very positive impact since joining Porterhouse at the start of the...
Infographic: China: How to keep up and win in the world’s fastest changing healthcare market
White Papers and Resources | August 1, 2019 | Inizio
Our latest infographic outlines the changes to the clinical trial process, accelerated drug approval, fast track of rare disease products and access opportunities in China's evolving healthcare environment.Find out more here-...